ADORA2A Polymorphisms Influence Methotrexate Adverse Events in Rheumatoid Arthritis

Nadja Kobold1, Barbara Jenko1, Matija Tomšič2,3

  • 1Institute of Biochemistry, Pharmacogenetics Laboratory, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Abstract

Insights

Single nucleotide polymorphisms in ADORA2A and ADORA3 genes may influence rheumatoid arthritis treatment with methotrexate. Certain ADORA2A gene variants are linked to fewer adverse events, suggesting potential as biomarkers for methotrexate therapy.

Area of Science:

  • Pharmacogenomics
  • Rheumatology
  • Molecular Biology

Background:

  • Methotrexate is a primary treatment for rheumatoid arthritis (RA), working by increasing adenosine levels.
  • Adenosine's anti-inflammatory effects are mediated through adenosine receptors 2A (ADORA2A) and 3 (ADORA3).
  • Genetic variations, specifically single nucleotide polymorphisms (SNPs) in ADORA2A and ADORA3, are common and may impact drug response.

Purpose of the Study:

  • To determine if specific tagging polymorphisms in the ADORA2A and ADORA3 genes affect patient response to methotrexate treatment for RA.
  • To identify potential genetic biomarkers for predicting methotrexate efficacy and adverse events in RA patients.

Main Methods:

  • Genotyping of 212 RA patients treated with methotrexate for selected tagging SNPs in ADORA2A and ADORA3 genes.
  • Analysis of associations between specific SNPs (e.g., ADORA3 rs35511654, ADORA2A rs2298383, rs2236624, rs5751876, rs35320474) and treatment outcomes.
  • Statistical analysis, including adjustments for clinical factors and haplotype analyses, to confirm significance.

Main Results:

  • A trend towards better methotrexate response was observed in RA patients with the ADORA3 rs35511654 G allele (P = 0.054).
  • Carriers of specific ADORA2A polymorphic alleles (rs2298383, rs2236624, rs5751876, rs35320474) showed a significantly lower likelihood of experiencing methotrexate-induced adverse events (P < 0.05).
  • All identified associations remained statistically significant after adjusting for clinical factors and were supported by haplotype analyses.

Conclusions:

  • Polymorphisms within the ADORA2A gene appear to influence the effectiveness and tolerability of methotrexate treatment in rheumatoid arthritis.
  • These ADORA2A gene variants show promise as predictive biomarkers for optimizing methotrexate therapy in RA patients.
  • Further research into ADORA2A and ADORA3 polymorphisms could lead to personalized treatment strategies for rheumatoid arthritis.

Related Concept Videos

Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
780
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.0K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
787
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
714
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
685
Integration of Synaptic Events01:28

Integration of Synaptic Events

Synaptic integration mainly includes the summation of graded potentials. Graded potentials, regardless of their type, cause subtle alterations in membrane voltage, resulting in either depolarization or hyperpolarization. These incremental changes, when combined or summed, can propel the neuron toward its threshold. Consider, for example, a membrane experiencing a +15 mV shift, causing it to depolarize from -70 mV to -55 mV. In this scenario, graded potentials govern the membrane's ability to...
3.6K